Rhythm Pharmaceuticals Stock
Price
Target price
€100.00
€100.00
-
-
-
€116.08
09.07.26 / Stuttgart Stock Exchange
WKN: A2H5A0 / Symbol: RYTM / Name: Rhythm Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Rhythm Pharmaceuticals Stock
With 41 Buy predictions and 1 Sell predictions Rhythm Pharmaceuticals is one of the favorites of our community.
As a result the target price of 116 € shows a slightly positive potential of 16.0% compared to the current price of 100.0 € for Rhythm Pharmaceuticals.
For the coming years our community has positive and negative things to say abot the Rhythm Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Rhythm Pharmaceuticals in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rhythm Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals | - | -0.505% | 29.605% | 66.949% | 5.348% | 593.662% | 500.610% |
| Evolus Inc | 0.240% | -1.678% | 1.279% | -28.994% | 7.486% | -9.178% | -43.126% |
| Heron Therapeutics Inc. | -4.440% | 0.915% | 8.194% | -80.064% | -66.338% | -65.909% | -96.867% |
| Genfit S.A. | -0.140% | 21.731% | 61.547% | 317.829% | 156.134% | 279.614% | 320.635% |
Comments
Rhythm Pharmaceuticals (RYTM) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) was given a new $151.00 price target by Canaccord Genuity Group Inc.. They now have a "buy" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat